Get your appointment reminders by text!
Text HEARTPLACE to 622622
or scan the QR CODE with your smart phone.
Dr. Nesbitt attended Baylor University where he received his undergraduate degree.
Dr. Routh specializes in Interventional Cardiology and Cardiovascular Disease.
Dr. Roffman specializes in Cardiovascular Disease.
HeartPlace is the past, present, and future of cardiology in North Texas. Founded almost 50 years ago, HeartPlace is the oldest and largest cardiovascular group in North Texas. From its small beginning in Dallas, HeartPlace has grown to over 70 physicians throughout the Dallas-Fort Worth metroplex. HeartPlace has been an innovator in cardiovascular services, introducing to the North Texas area procedures such as coronary angiography, angioplasty, coronary stenting, and electrophysiology. This dedication to innovative techniques and procedures has guaranteed our patients the latest and most up-to-date cardiovascular services...
Coronary artery bypass grafting (CABG) proves superior to percutaneous coronary intervention (PCI) for treating multivessel or left main coronary artery disease in diabetic patients, according to a study being published in Annals of Internal Medicine. Diabetes affects up to 400 million persons worldwide, with that number expected to increase significantly over the next two decades. Because patients with diabetes are more than twice as likely to develop cardiovascular disease, the optimal revascularization technique for these patients is an important unsolved question. Source: Medical News Today Read More Read More
People with diabetes who appear otherwise healthy may have a six-fold higher risk of developing heart failure regardless of their cholesterol levels, new Johns Hopkins Bloomberg School of Public Health research suggests. Source: MedicalXpress Read More Read More
To maximize stroke recovery, researchers may want to focus more on ways to support the side of the brain where the injury didn't occur, scientists report. Source: Science Daily Read More Read More
Dr. Vijay Ramanath performed the very first drug coated balloon angioplasty using the In.PACT Admiral device in Dallas Fort Worth. We have an exciting announcement! On Feb 4, 2015, our very own Dr. Vijay Ramanath of HeartPlace Plano West, performed the very first drug coated balloon angioplasty using the In.PACT Admiral device in Dallas Fort Worth at THR Plano. We are excited to be the first practice in the Dallas Fort Worth area to utilize this new cardiac procedure to treat Vascular Disease in Texas. Drug coated balloons are a brand new technology that will revolutionize how we treat arterial blockages in the upper legs. Current therapies including balloon angioplasty and stenting provide suboptimal long-term outcomes. Drug coated balloons provide delivery of a medication to the arterial wall that helps prevents re-narrowing of the previously treated blockage, without leaving any metal scaffolding in the artery which may limit future therapeutic options. Current data shows superiority of drug coated balloon angioplasty compared to conventional balloon angioplasty with regards to success in keeping the artery open post-treatment. Bellow are before and after pictures of this brand new procedure. You can clearly see the amazing results. "Before "After To read more about this exciting new procedure, please read the official press release from the FDA webpage here. At HeartPlace, we offer cardiovascular treatment and services led by prominent physicians recognized for their contributions to advancing patient care. HeartPlace provides compassionate and cutting-edge preventive, diagnostic, and therapeutic services. We are the oldest and largest cardiovascular group in North Texas. Our commitment to quality includes board certification of our physicians, accreditation of our imaging centers, and the latest technologies. HeartPlace prides itself on being able to deliver quality care whether it is a simple problem such as blood pressure or complicated procedures such as robotic surgery or cardiac transplantation. HeartPlace is the past, present, and future of cardiology in North Texas. Read More
Widely considered simply a malodorous toxic gas, hydrogen sulfide is now being studied for its probable role in regulating blood pressure, according to researchers. Source: Science Daily Read More Read More